<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 2</label>
  <p class="p" xmlns="">In vitro studies of cyclodextrin inclusion complexes.</p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th colspan="7" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" class="th">Biological Activity In Vitro</th>
  </tr>
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">CD Type</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Complexed Substance</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Sample</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Concentration</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Activity</th>
   <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Improved Characteristics</th>
   <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">References</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Hyptis martiusii</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Staphylococcus aureus</italic>
    <break class="break"/>
    <italic class="italic">Escherichia coli</italic>
    <break class="break"/>
    <italic class="italic">Pseudomonas eruginosa</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">1 mg/mL</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antibacterial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-staphylococcal activity of essential oil 
    <italic class="italic">H. martiusii</italic> and a synergistic effect when associated with gentamicin against Gram negative bacteria 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B26-ijms-20-00642" ref-type="bibr" class="xref">26</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SBE-β-CD 
    <break class="break"/>HP-β-CD 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Albendazole</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Ovarian tumor cell line OVCAR-3 and human ovarian epithelial cells (HOSE) Ovcar-3 cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">6–8 mg/mL</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The addition of 8.0 mg/mL and 7.0 mg/mL of (ABZ) to 40% CD solutions at 25 °C showed maximum complexation with SBE-β-CD &amp; HP-β-CD, respectively, at three days, with 2 weeks stability. [ABZ] complexed with SBE-β-CD showed potent cytotoxicity (in vitro &amp; in vivo) in ovarian tumour cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B65-ijms-20-00642" ref-type="bibr" class="xref">65</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Albendazole</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">4T1 murine mammary carcinoma</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.5 μM</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The IC 
    <sub class="sub">50</sub> value obtained for ABZ was 0.56 ± 0.02 μM while for the ABZ:C-β-CD complex was 0.41 ± 0.30 μM. Although ABZ:C-β-CD complex showed lower values of IC 
    <sub class="sub">50</sub> than ABZ, no statistically significant differences were observed 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B66-ijms-20-00642" ref-type="bibr" class="xref">66</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">α-bisabolol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Staphylococcus aureus</italic>
    <break class="break"/>
    <italic class="italic">Escherichia coli</italic>
    <break class="break"/>
    <italic class="italic">Pseudomonas eruginosa</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">1 mg/mL</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antibacterial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antibacterial effect upon 
    <italic class="italic">S. aureus</italic>, in combination with gentamicin 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B67-ijms-20-00642" ref-type="bibr" class="xref">67</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">γ-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Alamethicin</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Listeria monocytogenes</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.0625 mg/mL 
    <break class="break"/>1.0 mL 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antibacterial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Images of 
    <italic class="italic">L. monocytogenes</italic> exposed to γ-CD/alamethicin complex revealed microbial inactivation 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B68-ijms-20-00642" ref-type="bibr" class="xref">68</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">2-nonanone</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Botrytis cinerea</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">75.0 mg/L</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antimicrobial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antimicrobial tests for mycelial growth reduction under atmospheric conditions proved the fungistatic behaviour of the inclusion complexes against 
    <italic class="italic">Botrytis cinerea</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B69-ijms-20-00642" ref-type="bibr" class="xref">69</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Polyamine-β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Glycyrrhetic acid</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Cell lines and normal human lung fibroblast WI-38</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Satisfactory aqueous solubility, along with high thermal stability of inclusion complexes will be potentially useful for their application in the formulation and design of natural medicines</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B70-ijms-20-00642" ref-type="bibr" class="xref">70</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">α-CD 
    <break class="break"/>β-CD 
    <break class="break"/>HP-β-CD 
    <break class="break"/>Methylated-β-CD 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Estragole</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DPPH radical scavenging</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antioxidant</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antioxidant activity of estragole was increased by the formation of inclusion complexes with CDs. The formation of inclusion complexes allowed a controlled release of estragole</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B71-ijms-20-00642" ref-type="bibr" class="xref">71</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SBE-β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Nintedanib</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EpiIntestinal tissue model</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">1 μM</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Intestinal absorption</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The study demonstrated that cyclodextrin complexation increased stability of nintedanib in Phosphate-buffered saline (PBS) (pH 7.4) and simulated intestinal fluid (SIF). Bioactivity of nintedanib also improved. Complexation increased the transport of nintedanib across intestinal membrane and reduced efflux ratio</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B72-ijms-20-00642" ref-type="bibr" class="xref">72</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">HP-β-CD Methylated-β-CD 
    <break class="break"/>HP-γ-CD 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Linalool</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">E. coli</italic> and 
    <italic class="italic">S. aureus</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antibacterial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">A significant amount of linalool was preserved, due to enhancement of the thermal stability of linalool by the cyclodextrin inclusion complexation</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B73-ijms-20-00642" ref-type="bibr" class="xref">73</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">HP-β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Biochanin A (BCA)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Escherichia coli</italic>, 
    <italic class="italic">Pseudomonas aeruginosa</italic>, 
    <italic class="italic">Klebsiella pneumoniae</italic>, 
    <italic class="italic">Salmonella enteritidis</italic>, 
    <italic class="italic">Staphylococcus aureus</italic>, 
    <italic class="italic">Candida albicans</italic> and 
    <italic class="italic">Aspergillus niger</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.84–1.69 mg</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antimicrobial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The obtained minimum inhibitory concentration (MIC) values for analyzed bacteria strains were in the range of 0.84–1.69 mg/cm 
    <sup class="sup">3</sup>. The prepared inclusion complex expressed less effect against strains 
    <italic class="italic">E. coli</italic> and 
    <italic class="italic">K. pneumoniae</italic>. Moreover, BCA and inclusion complex did not show activity against fungus 
    <italic class="italic">A. niger</italic>. These obtained results indicated that the antimicrobial activity of BCA was not significantly changed after complexation 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B74-ijms-20-00642" ref-type="bibr" class="xref">74</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD HP-β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Ellagic acid (EA)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <italic class="italic">Candida albicans</italic>, 
    <italic class="italic">Proteus vulgaris</italic>, 
    <italic class="italic">Klebsiella pneumoniae</italic>, 
    <italic class="italic">Escherichia coli</italic>, 
    <italic class="italic">Pseudomonas aeruginosa</italic>, 
    <italic class="italic">Bacillus cereus</italic>, 
    <italic class="italic">Bacillus luteus</italic>, and 
    <italic class="italic">Listeria monocytogenes</italic>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">1 mg</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antimicrobial</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The greater antimicrobial activity of inclusion complexes compared with free EA was probably the result of the ability of CDs to release the drug readily from the inclusion complexes. The improved antimicrobial activity could be due to the increased aqueous solubility of EA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B75-ijms-20-00642" ref-type="bibr" class="xref">75</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">HP-β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Thalidomide</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Caco-2 cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Intestinal absorption</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Thalidomide was stable in the transport buffer throughout the entire period of 2 h. The acidification of samples prevented the hydrolysis of thalidomide with 93.6 ± 2.2% of the initial drug being detected at the end of the experiment</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B76-ijms-20-00642" ref-type="bibr" class="xref">76</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Ellagic acid (EA)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Protein denaturation and membrane stabilization assay</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">20 mg/mL</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
   <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">EACD (20 mg/mL) inclusion complex considerably protected the albumin from denaturation. EACD (20 mg/mL) was able to protect the erythrocyte membrane from lysis induced by heat (32.95%) and hypotonicity (45.72%)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B77-ijms-20-00642" ref-type="bibr" class="xref">77</xref>] 
   </td>
  </tr>
 </tbody>
</table>
